Prevalence and antimicrobial resistance of Campylobacter from wild birds of prey in Spain

Wild birds have been identified as a relevant reservoir of Campylobacter spp., therefore, a potential source of infection in humans and domestic animals. The objective of this study was to determine the occurrence of Campylobacter spp. on birds of prey in Spain. In addition, antibiotic resistance profiles of the isolates were evaluated. A total of 689 specimens of 28 raptor species were analyzed, with a resulting individual prevalence of 7.5%. C. jejuni was the most frequently isolated species (88.5%), followed by C. coli and C. lari (3.8% each). The occurrence of Campylobacter was significantly higher (p < 0.05) in nocturnal birds of prey (15.3%), in spring season (12.2%) and in carnivorous species (9.4%). Isolates displayed a remarkable resistance to nalidixic acid (69.9%), ciprofloxacin (69.9%), and tetracycline (55.6%), and a low resistance to streptomycin (6.7%).Our findings highlight the importance of birds of prey as reservoirs of Campylobacter strains and their significant role as carriers of antimicrobial resistance.     

自噬调节剂对感染日本脑炎病毒小鼠脑部细胞凋亡的影响

旨在研究自噬调控药物对感染日本脑炎病毒（Japanese encephalitis virus，JEV）小鼠脑部细胞凋亡的影响，本试验建立自噬调控药物处理的感染日本脑炎病毒小鼠的动物模型，其中，雷帕霉素为自噬诱导剂，渥漫青霉素及氯喹为自噬抑制剂。实验动物分成8组：DMEM对照组（Control）；JEV感染组（JEV）；JEV+雷帕霉素（Rapamycin）组（JEV+Rapa）；JEV+渥漫青霉素（Wortmannin）组（JEV+Wort）；JEV+氯喹（Chloroquine）组（JEV+CQ）；雷帕霉素组（Rapa）；渥漫青霉素组（Wort）；氯喹组（CQ）。观察不同处理组小鼠的临床症状；透射电镜观察小鼠脑部神经元及胶质细胞的线粒体损伤程度；Tunel染色观察统计小鼠脑部凋亡细胞分布；检测小鼠脑部凋亡因子及凋亡蛋白的表达量。与JEV+Rapa及JEV组相比较，JEV+Wort及JEV+CQ组小鼠出现轻微的神经症状，脑部神经元及胶质细胞线粒体轻度损伤，脑组织较少细胞发生凋亡。不同处理组小鼠脑部凋亡因子及凋亡蛋白的表达量变化差异不显著。综上表明，自噬抑制剂渥漫青霉素和氯喹可以在一定程度上抑制感染日本脑炎病毒小鼠脑组织中细胞凋亡的发生。     

Bacteria and antibiotic resistance detection in fractures of wild birds from wildlife rehabilitation centres in Spain

Anatomic adaptations make birds more prone to open fractures with exposed bone parts losing vascularization. As a result of this exposure, fractures are colonized by different microorganisms, including different types of bacteria, both aerobic and anaerobic, causing osteomyelitis in many cases. For this reason, antibiotic treatment is common. However, carrying out antibiotic treatment without carrying out a previous antibiogram may contribute to increased resistance against antibiotics, especially in migratory wild birds. In this paper, bacterial counts regarding fracture type, bacterial identification and antibiotic resistance have been analysed in wild birds from wildlife rehabilitation centres in Spain. The results obtained showed that open fractures had higher bacterial counts (CFU/mL) than closed ones. Bacteria in family Enterobacteriaceae, identified were Escherichia spp., Enterobacter spp., Shigella spp., Hafnia alvei, Proteus mirabilis, Leclercia adecarboxylata and Pantoea agglomerans. Other bacteria present in wild birds’ fractures were Aeromonas spp., Enterococcus spp. Bacillus wiedmannii and Staphylococcus sciuri. All species found presented resistance to at least one of the antibiotics used. Wild birds can be implicated in the introduction, maintenance and global spreading of antibiotic resistant bacteria and represent an emerging public health concern. Results obtained in this paper support the idea that it is necessary to take this fact into account before antibiotic administration to wild animals, since it could increase the number of bacteria resistant to antibiotics.     

Genetic diversity and antibiotic susceptibility of Staphylococcus aureus isolates from wild boars

We here report the occurrence of S. aureus in wild boars and characterize isolates genotypically and phenotypically in order to get knowledge about the occurrence of clonal lineages and genotypes in free-living wild animals. Forty-one S. aureus isolates obtained from 111 wild boars hunted in Lower Saxony, Germany, were investigated and compared to human and livestock isolates. The S. aureus belonged to multilocus sequence types ST1, ST7, ST30, ST133, ST425, ST804, ST890 and to the new ST3237, ST3238, ST3255 and ST3369. The livestock associated CC398-MRSA lineage, however, was not found. In addition to well-known spa types, the new types t14999, t15000, t15001 and t15002 were detected. Macrorestriction analysis revealed a variety of different SmaI fragment patterns. Most isolates were susceptible to all antimicrobials tested, including methicillin, and resistance was detected only to ampicillin, penicillin and erythromycin. PCR analysis confirmed the presence of staphylococcal enterotoxin genes (seh) in all t127-ST1 isolates. A high degree of genetic diversity was detected with many spa types and clonal lineages previously reported in humans and livestock animals.     

Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes

The marine environment is a rich source of biologically active molecules for the treatment of human diseases, especially cancer. The adaptation to unique environmental conditions led marine organisms to evolve different pathways than their terrestrial counterparts, thus producing unique chemicals with a broad diversity and complexity. So far, more than 36,000 compounds have been isolated from marine micro- and macro-organisms including but not limited to fungi, bacteria, microalgae, macroalgae, sponges, corals, mollusks and tunicates, with hundreds of new marine natural products (MNPs) being discovered every year. Marine-based pharmaceuticals have started to impact modern pharmacology and different anti-cancer drugs derived from marine compounds have been approved for clinical use, such as: cytarabine, vidarabine, nelarabine (prodrug of ara-G), fludarabine phosphate (pro-drug of ara-A), trabectedin, eribulin mesylate, brentuximab vedotin, polatuzumab vedotin, enfortumab vedotin, belantamab mafodotin, plitidepsin, and lurbinectedin. This review focuses on the bioactive molecules derived from the marine environment with anticancer activity, discussing their families, origin, structural features and therapeutic use.     

ACVIM Consensus Statement on Therapeutic Antimicrobial Use in Animals and Antimicrobial Resistance

The epidemic of antimicrobial resistant infections continues to challenge, compromising animal care, complicating food animal production and posing zoonotic disease risks. While the overall role of therapeutic antimicrobial use in animals in the development AMR in animal and human pathogens is poorly defined, veterinarians must consider the impacts of antimicrobial use in animal and take steps to optimize antimicrobial use, so as to maximize the health benefits to animals while minimizing the likelihood of antimicrobial resistance and other adverse effects. This consensus statement aims to provide guidance on the therapeutic use of antimicrobials in animals, balancing the need for effective therapy with minimizing development of antimicrobial resistance in bacteria from animals and humans.     

不同驱虫药驱虫后伊犁马血液生化指标变化的研究

[目的] 研究不同驱虫药对伊犁马血液生化指标的影响,为伊犁马科学驱虫及健康养殖提供参考。[方法] 将平均体重（265.5±35.6）kg、出生日期相近的40匹1岁伊犁马随机分为5组,每组8匹,分别为对照组、试验Ⅰ组、试验Ⅱ组、试验Ⅲ组和试验Ⅳ组。在相同的饲养管理和日粮营养水平条件下,对照组不驱虫,在试验开始第1天,试验Ⅰ组使用伊维菌素驱虫,试验Ⅱ组使用吡喹酮驱虫,试验Ⅲ组使用阿苯达唑驱虫,试验Ⅳ组使用伊维菌素和阿苯达唑的混合药剂驱虫;在试验第14天采集马匹血液样品,测定血浆氮代谢指标、葡萄糖及酶相关指标、脂代谢指标及金属离子指标。[结果] ①试验Ⅲ组总蛋白（TP）浓度最低,与对照组、试验Ⅰ组、试验Ⅱ组及试验Ⅳ组相比,分别降低了8.16%、7.15%、4.98%及6.62%（P>0.05）。对照组及各试验组白蛋白（ALB）、尿素（UREA）浓度均无显著（P>0.05）差异。与对照组相比,试验Ⅲ组及试验Ⅳ组血浆中UREA浓度分别降低了33.15%及36.10%（P>0.05）。②与对照组相比,试验Ⅰ组、试验Ⅱ组、试验Ⅲ组、试验Ⅳ组丙氨酸氨基转移酶（ALT）活力分别降低了26.51%、21.11%、47.14%及52.38%（P>0.05）。试验Ⅲ组血浆中碱性磷酸酶（ALP）活力低于对照组,降低了0.19%（P>0.05）。与对照组相比,试验Ⅱ组和试验Ⅳ组的乳酸脱氢酶（LDH）活力显著（P<0.05）升高,分别提高了17.84%、13.51%;谷草转氨酶（AST）活力分别提高了5.40%和4.08%（P>0.05）。③对照组血浆中甘油三酯（TG）、肌酐（CREA）及尿酸（UA）的含量与各试验组相比均无显著（P>0.05）差异。试验Ⅰ组及试验Ⅳ组血浆中CREA浓度较对照组分别提高13.38%和9.86%（P>0.05）。试验Ⅱ组血浆中胆碱酯酶（CHE）活力显著（P<0.05）高于试验Ⅲ组,提高了17.70%。④对照组血浆中Mg²⁺浓度与各试验组相比差异不显著（P>0.05）;试验Ⅲ组血浆中Ca²⁺浓度最低,与对照组、试验Ⅰ组、试验Ⅱ组及试验Ⅳ组相比,分别降低了23.44%、16.40%、25.89%及21.43%（P<0.05）。[结论] 综合来看,使用伊维菌素和阿苯达唑混合驱虫,对伊犁马血浆中的氮代谢、糖脂代谢指标及肝功能代谢酶活力改善效果更明显。     

Target and non-target site mechanisms of fungicide resistance and their implications for the management of crop pathogens

Fungicides are indispensable for high-quality crops, but the rapid emergence and evolution of fungicide resistance have become the most important issues in modern agriculture. Hence, the sustainability and profitability of agricultural production have been challenged due to the limited number of fungicide chemical classes. Resistance to site-specific fungicides has principally been linked to target and non-target site mechanisms. These mechanisms change the structure or expression level, affecting fungicide efficacy and resulting in different and varying resistance levels. This review provides background information about fungicide resistance mechanisms and their implications for developing anti-resistance strategies in plant pathogens. Here, our purpose was to review changes at the target and non-target sites of quinone outside inhibitor (QoI) fungicides, methyl-benzimidazole carbamate (MBC) fungicides, demethylation inhibitor (DMI) fungicides, and succinate dehydrogenase inhibitor (SDHI) fungicides and to evaluate if they may also be associated with a fitness cost on crop pathogen populations. The current knowledge suggests that understanding fungicide resistance mechanisms can facilitate resistance monitoring and assist in developing anti-resistance strategies and new fungicide molecules to help solve this issue. © 2023 Society of Chemical Industry.